|
FY2025
12 months to Sep 27, 2025
|
FY2024
12 months to Sep 28, 2024
|
FY2023
12 months to Sep 30, 2023
|
FY2022
12 months to Sep 24, 2022
|
FY2021
12 months to Sep 25, 2021
|
|
|---|---|---|---|---|---|
| Operating activities: | |||||
| Net earnings | |||||
| Adjustments to reconcile net earnings to net cash provided by operating activities | |||||
| Depreciation of fixed assets | |||||
| Amortization of intangibles and deferred costs | |||||
| Intangible asset impairment charges | |||||
| Losses (Gains) from disposals of property & equipment | |||||
| Non-cash plant shutdown expenses | |||||
| Share-based compensation | |||||
| Deferred income taxes | |||||
| Gain on insurance proceeds received for damage to property, plant, and equipment | |||||
| Gain on insurance proceeds received in excess of operating losses recognized | |||||
| (Gain) Loss on marketable securities | |||||
| Other | |||||
| Changes in assets and liabilities, net of effects from purchase of companies | |||||
| Decrease in accounts receivable | |||||
| (Increase) Decrease in inventories | |||||
| (Increase) Decrease in prepaid expenses | |||||
| Increase (Decrease) in accounts payable and accrued liabilities | |||||
| Net changes in other operating assets and liabilities | |||||
| Net cash provided by operating activities | |||||
| Investing activities: | |||||
| Payments for purchases of companies, net of cash acquired | |||||
| Purchases of property, plant and equipment | |||||
| Proceeds from redemption and sales of marketable securities | |||||
| Proceeds from disposal of property and equipment | |||||
| Other | |||||
| Proceeds from insurance for fixed assets | |||||
| Net cash (used in) investing activities | |||||
| Financing activities: | |||||
| Payments to repurchase common stock | |||||
| Proceeds from issuance of stock | |||||
| Borrowings under credit facility | |||||
| Repayment of borrowings under credit facility | |||||
| Payments for debt issuance costs | |||||
| Payments on finance lease obligations | |||||
| Payment of cash dividend | |||||
| Net cash (used in) financing activities | |||||
| Effect of Exchange Rate on Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Including Discontinued Operation | |||||
| Effect of exchange rates on cash and cash equivalents | |||||
| Net increase in cash and cash equivalents | |||||
| Cash and cash equivalents at beginning of period | |||||
| Cash and cash equivalents at end of period | |||||
Loading...